President Joe Biden’s administration will argue before a U.S. appeals court for the continuation of a federal rule that requires health insurance providers to cover preventive care services without additional charges for patients. This rule, part of the 2010 Affordable Care Act (ACA), is known as Obamacare, championed by former President Barack Obama.
Set to be deliberated by a panel of judges in the 5th U.S. Circuit Court of Appeals, the case originated from a lawsuit filed by various businesses, including Braidwood Management, a Christian wellness center in Texas. They oppose the mandate to cover HIV-preventing medication, specifically pre-exposure prophylaxis (PrEP), citing religious objections related to homosexuality and drug use.
Approved for preventing HIV infection, PrEP drugs are manufactured by Gilead Sciences and ViiV Healthcare. A district judge earlier ruled against enforcing the mandate for a variety of preventive services, raising concerns about the authority of the task force deciding the covered services.
The dispute raises issues that may impact patient costs for essential preventive services, such as HIV prevention and cancer screenings. However, services recommended before the ACA implementation, like breast cancer screening, are not affected by the ruling.
The 5th Circuit panel comprises Circuit Judges appointed by both Republican former President Donald Trump and Democrat President Joe Biden. This legal battle echoes previous challenges to the ACA, which have led to conflicting court decisions subsequently resolved by the U.S. Supreme Court.
The outcome of this case will determine the future of preventive care coverage and its impact on patients’ financial burden. Prominent stakeholders and legal experts closely watch as this important healthcare policy issue unfolds.
